ANS expands coverage for global development disorder treatment
On June 23, the Collegiate Board of Directors of the National Supplementary Health Agency (ANS) approved a normative that guarantees the expansion of the rules for health insurance coverage for patients with Global Developmental Disorders (GDD) (ICD F84), among which [...]
